10-(azepan-1-ylmethyl)-3,4,6,11-tetrahydro-1H-indeno[1,2-c]isoquinolin-5(2h)-one hydrochloride | 1233479-13-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 英文名称: 10-(azepan-1-ylmethyl)-3,4,6,11-tetrahydro-1H-indeno[1,2-c]isoquinolin-5(2h)-one hydrochloride
• 英文别名: 10-(Azepan-1-ylmethyl)-1,2,3,4,6,11-hexahydroindeno[1,2-c]isoquinolin-5-one;hydrochloride
• CAS: 1233479-13-4
• 化学式: C₂₃H₂₈N₂O*ClH
• 分子量: 384.949
• InChiKey: CZOJIDULGRJCDI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.62
• 重原子数：
  27
• 可旋转键数：
  2
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.52
• 拓扑面积：
  32.3
• 氢给体数：
  2
• 氢受体数：
  2

文献信息

• SUBSTITUTED TETRACYCLIC 1H-INDENO [1,2-B]PYRIDINE-2(5H)-ONE ANALOGS THEREOF AND USES THEREOF
  申请人：JAGTAP Prakash

  公开号：US20100261706A1

  公开（公告）日：2010-10-14

  Provided herein are tetracyclic 1H-indeno[1,2-b]pyridine-2(5H)-one analogs and derivatives, compositions comprising an effective amount of a tetracyclic 1H-indeno[1,2-b]pyridine-2(5H)-one analog and/or derivative and methods for treating or preventing an inflammatory disease, a reperfusion injury, diabetes mellitus, a diabetic complication, a reoxygenation injury resulting from organ transplantation, an ischemic condition, a neurodegenerative disease, renal failure, a vascular disease, a cardiovascular disease, an ocular or opthalmologic disease, cancer, a complication of prematurity, cardiomyopathy, retinopathy, nephropathy, contrast induced nephropathy, neuropathy, erectile dysfunction or urinary incontinence, comprising administering to a subject in need thereof an effective amount of a tetracyclic 1H-indeno[1,2-b]pyridine-2(5H)-one analog or derivative.

  本文提供四环1H-吲哚[1,2-b]吡啶-2(5H)-酮类似物和衍生物，包括含有效量四环1H-吲哚[1,2-b]吡啶-2(5H)-酮类似物和/或衍生物的组合物以及治疗或预防炎症性疾病、再灌注损伤、糖尿病、糖尿病并发症、器官移植引起的再氧化损伤、缺血症、神经退行性疾病、肾功能衰竭、血管疾病、心血管疾病、眼部或眼科疾病、癌症、早产并发症、心肌病、视网膜病、肾病、造影剂诱导性肾病、神经病和勃起功能障碍或尿失禁的方法，包括向需要的受体施用有效量的四环1H-吲哚[1,2-b]吡啶-2(5H)-酮类似物或衍生物。
• ARYLSULFONYLAMINOMETHYLPHOSPHONIC ACID DERIVATIVES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS
  申请人：Langkopf Elke

  公开号：US20100261677A1

  公开（公告）日：2010-10-14

  The invention relates to substituted arylsulphonylaminomethylphosphonic acid derivatives of general formula (I) wherein the groups R a to R f , A and Z are defined as mentioned in the specification and claims, which are suitable for preparing a medicament for the treatment of metabolic disorders, particularly type 1 or type 2 diabetes mellitus.

  本发明涉及一种通式(I)的取代芳基磺酰氨甲基膦酸衍生物，其中R到Rf，A和Z的基团如说明书和权利要求中所述，适用于制备用于治疗代谢性疾病，特别是1型或2型糖尿病的药物。
• PYRROLIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
  申请人：Boehringer Ingelheim International GmbH

  公开号：EP2997024B1

  公开（公告）日：2018-03-28
• US20140343083A1
  申请人：——

  公开号：US20140343083A1

  公开（公告）日：2014-11-20
• US9278954B2
  申请人：——

  公开号：US9278954B2

  公开（公告）日：2016-03-08